American Well Corporation v. Indegene Limited

CourtDistrict Court, D. New Jersey
DecidedDecember 19, 2025
Docket3:25-cv-01318
StatusUnknown

This text of American Well Corporation v. Indegene Limited (American Well Corporation v. Indegene Limited) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Well Corporation v. Indegene Limited, (D.N.J. 2025).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

AMERICAN WELL CORPORATION,

Plaintiff, Civil Action No. 25-1318 (ZNQ) (JTQ)

v. OPINION

INDEGENE LIMITED,

Defendant.

QURAISHI, District Judge THIS MATTER comes before the Court upon a Motion to Dismiss filed by Defendant Indegene Limited (“Defendant” or “Indegene”). (ECF No. 11.) Defendant filed a memorandum of law in support of its Motion. (“Moving Br.,” ECF No. 11-1.) Plaintiff American Well Corporation (“Plaintiff” or “Amwell”) filed an Opposition (ECF No. 17), to which Defendant replied (ECF No. 18). The Court has carefully considered the parties’ submissions and decides the Motion without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1. For the reasons set forth below, the Court will GRANT Defendant’s Motion. I. BACKGROUND AND PROCEDURAL HISTORY This action arises out of a contract dispute between Amwell and Indegene. Under a partner agreement between the parties (the “Partner Agreement”), Defendant was authorized to license and sell Plaintiff’s software to third-party customers. (“Compl.,” ECF No. 1 ¶ 26.) As will be explained in more detail below, the dispute centers on whether the Partner Agreement requires Defendant to pay a Subscription Fee to Plaintiff even though Defendant did not license or sell Plaintiff’s software to any third-party customers. As alleged, Plaintiff develops and maintains software application platforms for the provision of telehealth services. (Id. ¶ 2.) One of Plaintiff’s subsidiaries, Conversa Health LLC

(“Conversa”), has proprietary software “that enables individual end users to engage in automated digital conversations about their health, health education, and related matters.” (Id. ¶ 27.) Defendant offers research, development, and management services to healthcare and pharmaceutical companies. (Id. ¶ 7.) On December 23, 2021, Plaintiff and Defendant entered into the Partner Agreement. (Id. ¶ 17.) Pursuant to Section 2.1 of the Partner Agreement, Defendant was granted a “non-exclusive, non-transferable license and right to use, market, resell and distribute the Conversa Services in the [United States].” (Partner Agreement (DX B) § 2.1; see also Compl. ¶ 26.)1 “Conversa Services” is defined in the Partner Agreement as: (a) the hosting, management, and operation of Conversa’s proprietary Software-as-a-Service (“SaaS”) that enables Conversa to provide Customer with automated, interactive digital conversation services (or “chat” sessions) with End Users, including all know-how, devices, methods, processes, other technologies and inventions, technical or functional descriptions, requirements, documentation, instructions, deliverables, user design appearance, content used in chat sessions, and content and functionality of Customer dashboards and related items used by Conversa to provide such Services; (b) related services provided by Conversa to Customer, as described in the applicable Service Order; and (c) any optional Implementation Services provided by Conversa to Customer pursuant to an applicable Service Order.

1 References to “DX” refer to the Exhibits accompanying Defendant’s Declaration of Cameron A. Smith at ECF Nos. 11-2–6 and attached to Defendant’s Motion to Dismiss. References to “PX” refer to the Exhibits attached to Plaintiff’s Complaint at ECF Nos. 1-1–4. (Compl. ¶ 27; see also Partner Agreement (DX B) § 1.4.) Plaintiff and Defendant also executed Service Order #1 the same day as the Partner Agreement. (Id. ¶ 31.) According to Plaintiff, the Service Order “concerned the configuration and development by Amwell and Indegene Limited of a program with a focus on medication adherence

for Indegene Limited’s customers.” (Id. ¶ 34.) The development and implementation of this program was projected in the Statement of Work attached to the Service Order. (Id. ¶ 36.) The term of the Service Order was for 12 months and had an annual subscription fee of $250,000. (Id. ¶ 38.) The annual fee was divided into two payments, with 50% of the annual fee payable on March 1, 2022, and the remaining 50% payable on July 1, 2022. (Id. ¶ 39.) Consistent with the Service Order, Plaintiff issued its first invoice to Defendant on March 1, 2022 for $125,000. (Id.¶ 48.) On July 1, 2022, Plaintiff issued its second invoice to Defendant for the remaining $125,000. (Id. ¶ 50.) According to Plaintiff, Defendant “has failed to timely pay the monies owed to Amwell under the Partner Agreement and Service Order . . . and efforts by Amwell to collect payment from Indegene Limited have been ignored, rejected, or otherwise

unproductive.” (Id. ¶ 52.) Instead of making the requested payments, Defendant sent a letter to Plaintiff on July 12, 2023, informing Plaintiff that it was “unable to comply with the request for payment due to the lack of service provided.” (Indegene Letter (PX C) at 1; see also Compl. ¶ 53.) According to Defendant’s letter, “[t]he primary and sole objective under the said Partnership Agreement . . . is to enable Indegene to offer to its Customers a license to use specified Conversa Services, Conversa consulting services to customize and configure Conversa Services, and related support and ancillary services.” (Indegene Letter (PX C) at 1.) Because Defendant did not have any customers who licensed the Conversa products or services, Defendant maintained that it did not have a valid Service Order in compliance with Section 1.19 of the Partner Agreement. (Id.) That provision states in full: “Service Order” means the customized ordering document to be executed by Conversa and Partner that corresponds to each Statement of Work that includes specified Conversa Services, including any optional Implementation Services. For the avoidance of doubt, each Service Order between Conversa and Partner will be identical to the applicable corresponding Statement of Work between Partner and Customer covering the scope and details of any applicable license for Conversa Services (except the pricing and payment terms in the Statement of Work will be agreed between Partner and Customer.) A copy of the current version of the Service Order is set out in Exhibit 5. (Partner Agreement (DX B) § 1.19.) Defendant went on to request Plaintiff withdraw its request for payment because “it does not align with the principle of [the Partner] Agreement mutually agreed and executed.” (Indegene Letter (PX C) at 2.) Thereafter, Plaintiff sent a letter to Defendant putting it “on formal notice that Indegene Limited is in material breach of the Partner Agreement and Service Order due to non-payment of annual subscription fees.” (Compl. ¶ 55.) According to Plaintiff, “[t]he payment obligation for the subscription fees in the Service Order is triggered irrespective of Indegene’s use or nonuse of [Amwell’s] product.” (Amwell Letter (PX D) at 2.) To date, Defendant has not paid the annual subscription fee. (Compl. ¶ 57.) Accordingly, Plaintiff filed this action against Defendant alleging a single cause of action for Breach of Contract. The Partner Agreement is governed by Delaware Law. (Partner Agreement (DX B) § 14.2.) II. SUBJECT MATTER JURISDICTION The Court has subject matter jurisdiction over this action given the diversity of the parties and the value of the claim at issue exceeding $75,000 pursuant to 28 U.S.C. § 1332(a). III. LEGAL STANDARD 1. Rule 12(b)(6) A district court may grant a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim upon which relief can be granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
American Well Corporation v. Indegene Limited, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-well-corporation-v-indegene-limited-njd-2025.